Voya Investment Management LLC Has $1.23 Million Stock Holdings in Embecta Corp. $EMBC

Voya Investment Management LLC increased its holdings in shares of Embecta Corp. (NASDAQ:EMBC) by 161.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 87,054 shares of the company’s stock after purchasing an additional 53,805 shares during the quarter. Voya Investment Management LLC’s holdings in Embecta were worth $1,228,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of EMBC. Comerica Bank grew its stake in Embecta by 65.7% during the 1st quarter. Comerica Bank now owns 50,641 shares of the company’s stock valued at $646,000 after acquiring an additional 20,079 shares in the last quarter. American Century Companies Inc. grew its position in Embecta by 36.3% during the second quarter. American Century Companies Inc. now owns 5,195,948 shares of the company’s stock valued at $50,349,000 after purchasing an additional 1,382,537 shares in the last quarter. Raymond James Financial Inc. increased its stake in Embecta by 2.1% in the 1st quarter. Raymond James Financial Inc. now owns 326,156 shares of the company’s stock valued at $4,158,000 after buying an additional 6,640 shares during the period. Squarepoint Ops LLC lifted its position in Embecta by 103.6% in the 2nd quarter. Squarepoint Ops LLC now owns 403,412 shares of the company’s stock worth $3,909,000 after buying an additional 205,311 shares in the last quarter. Finally, State of Alaska Department of Revenue boosted its stake in shares of Embecta by 15.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 401,112 shares of the company’s stock valued at $3,885,000 after buying an additional 52,566 shares during the period. 93.83% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Embecta in a research note on Wednesday, October 8th. Wall Street Zen raised Embecta from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Zacks Research downgraded Embecta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 7th. Finally, BTIG Research reissued a “buy” rating on shares of Embecta in a research note on Tuesday, November 25th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $18.50.

Embecta Trading Up 1.8%

Shares of Embecta stock opened at $12.07 on Wednesday. The firm has a fifty day simple moving average of $12.97 and a 200-day simple moving average of $12.67. The stock has a market capitalization of $714.66 million, a price-to-earnings ratio of 7.40 and a beta of 1.10. Embecta Corp. has a 1-year low of $9.20 and a 1-year high of $21.23.

Embecta (NASDAQ:EMBC) last released its earnings results on Tuesday, November 25th. The company reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.04. Embecta had a net margin of 8.83% and a negative return on equity of 24.62%. The firm had revenue of $263.30 million during the quarter, compared to analyst estimates of $265.66 million. During the same quarter in the previous year, the business earned $0.45 EPS. The business’s revenue was down 7.7% on a year-over-year basis. Embecta has set its FY 2026 guidance at 2.800-3.000 EPS. As a group, research analysts predict that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Friday, December 5th were paid a dividend of $0.15 per share. The ex-dividend date was Friday, December 5th. This represents a $0.60 annualized dividend and a yield of 5.0%. Embecta’s dividend payout ratio is presently 36.81%.

About Embecta

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.